A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT06055374 · WITHDRAWN
Trial details
- NCT number
- NCT06055374
- Sponsor
- Brexogen Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2025-04-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.